Derivatives Of 1,2 Diketo Propane And Its Role In Anti Cancer Activity | 1123
Journal of Cancer Science & Therapy
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Cancer which has become the most devastating disease of this era is an uncontrolled growth of cells through division beyond
normal limits. Till now in research there are a number of therapies which have come up to fight against this disease. But
unfortunately most of them are so toxic and injurious that the medicines become cause of the death of the patient. Among the
safer therapeutics, Methylglyoxal is a one suggested by Albert Szent-Gyorgyi in 1963 which he termed as Retine.
This dicarbonyl compound which has both an aldehyde and ketone groups has been found to have anti-cancer property and
produced by metabolic pathways like ?glycolysis? to fight cancer in biological system through the destruction of mitochondria
inside our body and it has been found that heat shock protein 27 (Hsp27) as a specific target of posttranslational modification
by methylglyoxal in human metastatic melanoma cells. Biological origin and its role in anti-cancer activity are well established
by Ray et al.
We have synthesized many derivatives which are modification of methylglyoxal and tested on cancer cell lines like B-16,
HeLa, YAC-1 etc and found the results very promising. The compounds like 1,2-diketobutane , 3-methoxy and 3-ethoxy 1,2
diketopropane , 3(4methoxy) 1,2 diketopropane and many other derivatives have been synthesized and derivatives effectively
inhibit the growth of cancerous cells and not causing any harm to the healthy cells. Preliminary treatment of these derivatives
show, the tumoral growth is completely subsided by the healthy cells. Early results on animal models are highly encouraging.
Arindam Pramanik has completed his post graduation (MSc in Microbiology) at the age of 23 from University of Kalyani and currently doing research
activities in the Nanometerials laboratory of Indian Institute of Technology (IIT), Kharagpur, India. His area of focus is on nanomedicines and its
application on cancer and microbial system. He has 2 recent publications in international journals in 2010 and few more under communication.
Susmita Pramanik has completed her post graduation (MSc in Biochemistry) from Bangalore University, India and currently residing in Windsor
Ontario, Canada. She has 3 publications in reputed international journals.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals